BD to Distribute Epistem TB Test | GenomeWeb

NEW YORK (GenomeWeb News) – Epistem said today that Becton Dickinson will distribute the firm's Mycobacterium tuberculosis test on a global basis, excluding India and the Indian Sub-Continent.

The molecular test, which recently received the CE-IVD Mark, runs on Epistem's Genedrive platform.

Manchester, UK-based Epistem said that it will receive an upfront payment of $1 million and further milestone payments up to $3 million. In addition, the agreement includes escalating supply volumes over the next five years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.